Issue link: http://catalog.e-digitaleditions.com/i/114936
compensation plans were previously submitted to and approved by our shareholders. Additional information regarding our equity compensation plans appear in Note 1 and Note 8 to the Consolidated Financial Statements in Item 8 of this report. At December 31, 2012, we also had a stock performance incentive award program pursuant to which shares of our common stock have been and may be issued to certain employees with respect to performance. The status of these plans as of December 31, 2012 follows: Number of shares of common stock to be issued upon exercise of outstanding options, warrants and rights Plan category Equity compensation plans approved by shareholders ITEM 13. Weighted-average exercise price of outstanding options, warrants and rights Number of shares of common stock remaining available for future issuance under equity compensation plans (excluding shares reflected in the first column) 21,552,922 $47.89 33,066,151 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. The information under the caption "Information About the Board of Directors and Corporate Governance Matters���Independent Directors" and "Information About the Board of Directors and Corporate Governance Matters���Certain Relationships and Related Party Transactions" in the 2013 proxy statement is incorporated herein by reference. ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES. The information under the caption "Proposal 2���Ratification of Appointment of Our Independent Registered Public Accounting Firm ���Relationship with Ernst & Young LLP" in the 2013 proxy statement is incorporated herein by reference. PART IV ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES. (a) 1. Financial Statements The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report. Report of Independent Registered Public Accounting Firm on Financial Statements Consolidated Statements of Earnings for the Years Ended December 31, 2012, 2011 and 2010 Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2012, 2011 and 2010 Consolidated Balance Sheets as of December 31, 2012 and 2011 Consolidated Statements of Shareholders��� Equity for the Years Ended December 31, 2012, 2011 and 2010 Consolidated Statements of Cash Flows for the Years Ended December 31, 2012, 2011 and 2010 Notes to Consolidated Financial Statements (a) 2. Financial Statement Schedules The consolidated financial statement schedule (Schedule II) of Stryker Corporation and its subsidiaries has been submitted as a separate section of this report following the signature page. All other schedules for which provision is made in the applicable accounting regulation of the U.S. Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted. (a) 3. Exhibits A list of exhibits required to be filed as part of this report is set forth in the Exhibit Index, which immediately precedes such exhibits, and is incorporated herein by reference. (c) Financial Statement Schedules 44 21 22 22 23 24 25 26